We are live on ! Find out more
KLWA

Kelly Lawrence W & Associates Portfolio holdings

AUM $360M
1-Year Est. Return 16.9%
This Fund
S&P 500
This Quarter Est. Return
-1.81%
1 Year Est. Return
+16.9%
3 Year Est. Return
+58.93%
5 Year Est. Return
+78.96%
10 Year Est. Return
+418.66%
AUM
$358M
AUM Growth
-$7.11M
Cap. Flow
+$5.78M
Cap. Flow %
1.61%
Top 10 Hldgs %
45.88%
Holding
187
New
7
Increased
35
Reduced
27
Closed
7

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$1.34M
2
PYPL icon
PayPal
PYPL
+$1.09M
3
HD icon
Home Depot
HD
+$781K
4
CRM icon
Salesforce
CRM
+$733K
5
AMT icon
American Tower
AMT
+$696K

Sector Composition

Rank Sector Weight
1 Technology 28.73%
2 Healthcare 15.79%
3 Financials 13.72%
4 Communication Services 11.03%
5 Consumer Staples 9.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVX icon
26
Chevron
CVX
$388B
$3.23M 0.9%
22,517
-624
-3% -$95.2K
AMAT icon
27
Applied Materials
AMAT
$424B
$3.18M 0.89%
38,862
+1,800
+5% +$174K
CRM icon
28
Salesforce
CRM
$165B
$3.14M 0.88%
21,825
+4,325
+25% +$733K
CSCO icon
29
Cisco
CSCO
$447B
$2.97M 0.83%
74,252
-1,602
-2% -$71.1K
HXL icon
30
Hexcel
HXL
$7.74B
$2.41M 0.67%
46,530
+120
+0.3% +$6.99K
MSFT icon
31
Microsoft
MSFT
$3.69T
$2.13M 0.6%
9,155
WWD icon
32
Woodward
WWD
$21.2B
$1.95M 0.54%
24,305
-225
-0.9% -$21.2K
ABBV icon
33
AbbVie
ABBV
$443B
$1.77M 0.5%
13,218
-250
-2% -$35.9K
BRK.B icon
34
Berkshire Hathaway Class B
BRK.B
$1.09T
$1.55M 0.43%
5,812
+2,300
+65% +$654K
EW icon
35
Edwards Lifesciences
EW
$53.4B
$1.43M 0.4%
17,325
-5,500
-24% -$529K
RITM.PRB icon
36
Rithm Capital Corp 7.125% Series B Preferred Stock
RITM.PRB
$285M
$1.41M 0.4%
74,483
+15,550
+26% +$328K
WFC.PRL icon
37
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
$1.32M 0.37%
1,134
+15
+1% +$18.8K
JPM icon
38
JPMorgan Chase
JPM
$965B
$1.31M 0.36%
12,500
-112
-0.9% -$12.9K
SHEL icon
39
Shell
SHEL
$248B
$1.28M 0.36%
25,757
SCHW
40
Charles Schwab
SCHW
$190B
$1.23M 0.34%
17,068
-150
-0.9% -$10.4K
VRSN icon
41
VeriSign
VRSN
$26B
$1.04M 0.29%
5,995
GLD icon
42
SPDR Gold Trust
GLD
$142B
$943K 0.26%
6,100
+3,200
+110% +$515K
AMZN icon
43
Amazon
AMZN
$2.86T
$793K 0.22%
7,020
+5,260
+299% +$665K
PFE icon
44
Pfizer
PFE
$153B
$771K 0.22%
17,623
HUM icon
45
Humana
HUM
$46.2B
$728K 0.2%
1,500
DOW icon
46
Dow Inc
DOW
$21.9B
$683K 0.19%
15,547
AGNCO icon
47
AGNC Investment Dep Shares 1/1000 Cumulative Series E
AGNCO
$652K 0.18%
31,667
+10,500
+50% +$231K
AVY icon
48
Avery Dennison
AVY
$13.6B
$635K 0.18%
3,900
GILD icon
49
Gilead Sciences
GILD
$171B
$610K 0.17%
9,881
-1,649
-14% -$104K
VRTX icon
50
Vertex Pharmaceuticals
VRTX
$131B
$610K 0.17%
2,108

Similar funds

Kelly Lawrence W & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Kelly Lawrence W & Associates held 187 positions worth $358M, down 1.9% from $365M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Kelly Lawrence W & Associates's Q3 2022 filing shows 7 new, 35 increased, 27 reduced and 7 closed positions. Its largest new stake was Medtronic: 6,000 shares worth $484K. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $3.92M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

  • Kelly Lawrence W & Associates's largest Q3 2022 buy was Medtronic: 6,000 shares worth $484K.
  • Kelly Lawrence W & Associates added most to Walt Disney in Q3 2022, an estimated $1.34M increase.
  • Kelly Lawrence W & Associates's biggest Q3 2022 reduction was Costco, cutting an estimated $731K.
  • Kelly Lawrence W & Associates fully exited State Street SPDR S&P 500 ETF Trust in Q3 2022, selling an estimated $3.92M.
  • Kelly Lawrence W & Associates's ten largest holdings make up 46% of its $358M portfolio in Q3 2022.
  • Kelly Lawrence W & Associates opened 7 new positions and closed 7 in Q3 2022.
  • Kelly Lawrence W & Associates's portfolio value fell 1.9% quarter-over-quarter to $358M.

Based on Kelly Lawrence W & Associates's 13F filing for Q3 2022, filed 15 Nov 2022.